{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Control+I&page=9", "query": { "intervention": "Control I", "page": 9 }, "page_size": 10 }, "pagination": { "page": 9, "page_size": 10, "total_count": 2204, "total_pages": 221, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Control+I&page=10&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Control+I&page=8&page_size=10" }, "source": "remote", "last_synced_at": "2026-10-23T02:01:42.752Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT03092102", "title": "The Safety, Tolerability and Pharmacokinetic Study of HEC585 in Healthy Male and Female Subjects", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Idiopathic Pulmonary Fibrosis" ], "interventions": [ { "name": "HEC585", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Sunshine Lake Pharma Co., Ltd.", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "60 Years", "sex": "ALL", "summary": "18 Years to 60 Years" }, "enrollment_count": 136, "start_date": "2017-05-20", "completion_date": "2019-02-25", "has_results": false, "last_update_posted_date": "2020-07-27", "last_synced_at": "2026-10-23T02:01:42.752Z", "location_count": 1, "location_summary": "Madison, Wisconsin", "locations": [ { "city": "Madison", "state": "Wisconsin" } ], "official_url": "https://clinicaltrials.gov/study/NCT03092102" }, { "nct_id": "NCT02283853", "title": "Phase 3 Efficacy and Safety Study of BG00012 in Pediatric Participants With Relapsing-Remitting Multiple Sclerosis (RRMS)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Relapsing-Remitting Multiple Sclerosis" ], "interventions": [ { "name": "dimethyl fumarate", "type": "DRUG" }, { "name": "Interferon β-1a", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Biogen", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "10 Years", "maximum_age": "17 Years", "sex": "ALL", "summary": "10 Years to 17 Years" }, "enrollment_count": 156, "start_date": "2014-08-28", "completion_date": "2025-07-08", "has_results": true, "last_update_posted_date": "2026-05-19", "last_synced_at": "2026-10-23T02:01:42.752Z", "location_count": 2, "location_summary": "Boston, Massachusetts • Charlottesville, Virginia", "locations": [ { "city": "Boston", "state": "Massachusetts" }, { "city": "Charlottesville", "state": "Virginia" } ], "official_url": "https://clinicaltrials.gov/study/NCT02283853" }, { "nct_id": "NCT05173675", "title": "Empathy in Action: Sunshine Calls for Life With Diabetes", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Diabetes Mellitus, Type 2", "Diabetes", "Mental Health", "Health Behavior" ], "interventions": [ { "name": "Empathy in Action for life with diabetes.", "type": "BEHAVIORAL" }, { "name": "Control Phase 2 Materials Only", "type": "BEHAVIORAL" } ], "intervention_types": [ "BEHAVIORAL" ], "sponsor": "University of Texas at Austin", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "21 Years", "maximum_age": "70 Years", "sex": "ALL", "summary": "21 Years to 70 Years" }, "enrollment_count": 260, "start_date": "2022-02-12", "completion_date": "2024-04-29", "has_results": false, "last_update_posted_date": "2024-05-07", "last_synced_at": "2026-10-23T02:01:42.752Z", "location_count": 9, "location_summary": "Austin, Texas • Bastrop, Texas • Cedar Park, Texas + 3 more", "locations": [ { "city": "Austin", "state": "Texas" }, { "city": "Austin", "state": "Texas" }, { "city": "Austin", "state": "Texas" }, { "city": "Austin", "state": "Texas" }, { "city": "Bastrop", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT05173675" }, { "nct_id": "NCT06182267", "title": "Maximal Use Study to Determine the Pharmacokinetics of L-arginine After Exaggerated Oral Use of COL101", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Caries,Dental" ], "interventions": [ { "name": "L Arginine", "type": "DRUG" }, { "name": "Sodium Fluoride", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Colgate Palmolive", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "18 Years to 65 Years" }, "enrollment_count": 29, "start_date": "2023-11-27", "completion_date": "2023-12-22", "has_results": false, "last_update_posted_date": "2024-01-02", "last_synced_at": "2026-10-23T02:01:42.752Z", "location_count": 1, "location_summary": "Fair Lawn, New Jersey", "locations": [ { "city": "Fair Lawn", "state": "New Jersey" } ], "official_url": "https://clinicaltrials.gov/study/NCT06182267" }, { "nct_id": "NCT00616434", "title": "A Phase 2 Study of Interferon Beta-1a (Avonex®) in Ulcerative Colitis", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Active Ulcerative Colitis" ], "interventions": [ { "name": "BG9418 (Interferon beta-1a)", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Biogen", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "18 Years to 65 Years" }, "enrollment_count": 123, "start_date": "2008-05", "completion_date": "2010-03", "has_results": true, "last_update_posted_date": "2014-08-13", "last_synced_at": "2026-10-23T02:01:42.752Z", "location_count": 5, "location_summary": "Birmingham, Alabama • Lakewood, Colorado • Bristol, Connecticut + 2 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Lakewood", "state": "Colorado" }, { "city": "Bristol", "state": "Connecticut" }, { "city": "Wellesley Hills", "state": "Massachusetts" }, { "city": "Oklahoma City", "state": "Oklahoma" } ], "official_url": "https://clinicaltrials.gov/study/NCT00616434" }, { "nct_id": "NCT00877032", "title": "Safety And Tolerability Study Of RN6G In Patients With Dry, Age-Related Macular Degeneration", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Age-Related Maculopathy", "Age-Related Maculopathies", "Eye Diseases", "Retinal Degeneration", "Macular Degeneration" ], "interventions": [ { "name": "RN6G", "type": "BIOLOGICAL" }, { "name": "Placebo", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "Pfizer", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 57, "start_date": "2009-04", "completion_date": "2011-07", "has_results": true, "last_update_posted_date": "2015-03-31", "last_synced_at": "2026-10-23T02:01:42.752Z", "location_count": 20, "location_summary": "Phoenix, Arizona • Glendale, California • Inglewood, California + 5 more", "locations": [ { "city": "Phoenix", "state": "Arizona" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "Glendale", "state": "California" }, { "city": "Inglewood", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT00877032" }, { "nct_id": "NCT06022822", "title": "Placebo-Controlled Trial of Urolithin A Supplementation in Men With Prostate Cancer Undergoing Radical Prostatectomy, URO-PRO Trial", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Prostate Adenocarcinoma" ], "interventions": [ { "name": "Biopsy Procedure", "type": "PROCEDURE" }, { "name": "Biospecimen Collection", "type": "PROCEDURE" }, { "name": "Placebo Administration", "type": "DRUG" }, { "name": "Urolithin A Supplement", "type": "DIETARY_SUPPLEMENT" } ], "intervention_types": [ "PROCEDURE", "DRUG", "DIETARY_SUPPLEMENT" ], "sponsor": "National Cancer Institute (NCI)", "sponsor_class": "NIH", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "MALE", "summary": "18 Years and older · Male only" }, "enrollment_count": 90, "start_date": "2024-09-12", "completion_date": "2027-05-01", "has_results": false, "last_update_posted_date": "2026-08-25", "last_synced_at": "2026-10-23T02:01:42.752Z", "location_count": 5, "location_summary": "Los Angeles, California • Chicago, Illinois • Durham, North Carolina + 1 more", "locations": [ { "city": "Los Angeles", "state": "California" }, { "city": "Chicago", "state": "Illinois" }, { "city": "Chicago", "state": "Illinois" }, { "city": "Durham", "state": "North Carolina" }, { "city": "Madison", "state": "Wisconsin" } ], "official_url": "https://clinicaltrials.gov/study/NCT06022822" }, { "nct_id": "NCT00600665", "title": "Effectiveness of a Computerized Tool (PAINRelieveIt) to Help Manage Pain Related to Sickle Cell Disease", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Anemia, Sickle Cell", "Hemoglobin SC Disease" ], "interventions": [ { "name": "PAINReportIt (Phase 1 + 2)", "type": "BEHAVIORAL" }, { "name": "PAINUCope (Phase 1)", "type": "BEHAVIORAL" }, { "name": "PAINConsultN (Phase 2)", "type": "BEHAVIORAL" }, { "name": "PAINUCope (Phase 2)", "type": "BEHAVIORAL" } ], "intervention_types": [ "BEHAVIORAL" ], "sponsor": "University of Illinois at Chicago", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 279, "start_date": "2007-02", "completion_date": "2014-06", "has_results": true, "last_update_posted_date": "2026-08-04", "last_synced_at": "2026-10-23T02:01:42.752Z", "location_count": 1, "location_summary": "Chicago, Illinois", "locations": [ { "city": "Chicago", "state": "Illinois" } ], "official_url": "https://clinicaltrials.gov/study/NCT00600665" }, { "nct_id": "NCT04799119", "title": "Multi-site Animal Assisted Intervention for Children With DD and Their Family Dog", "overall_status": "ACTIVE_NOT_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Physical Activity", "Social Wellbeing" ], "interventions": [ { "name": "Do As I Do (DAID) dog training", "type": "BEHAVIORAL" } ], "intervention_types": [ "BEHAVIORAL" ], "sponsor": "Oregon State University", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "10 Years", "maximum_age": "17 Years", "sex": "ALL", "summary": "10 Years to 17 Years" }, "enrollment_count": 100, "start_date": "2021-02-04", "completion_date": "2026-08-01", "has_results": false, "last_update_posted_date": "2025-11-18", "last_synced_at": "2026-10-23T02:01:42.752Z", "location_count": 1, "location_summary": "Corvallis, Oregon", "locations": [ { "city": "Corvallis", "state": "Oregon" } ], "official_url": "https://clinicaltrials.gov/study/NCT04799119" }, { "nct_id": "NCT00823732", "title": "Effects of Palliative Care on Quality of Life and Symptom Control in Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer That Cannot Be Removed by Surgery", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Lung Cancer" ], "interventions": [ { "name": "educational intervention", "type": "OTHER" }, { "name": "medical chart review", "type": "OTHER" }, { "name": "questionnaire administration", "type": "OTHER" }, { "name": "end-of-life treatment/management", "type": "PROCEDURE" }, { "name": "psychosocial assessment and care", "type": "PROCEDURE" }, { "name": "quality-of-life assessment", "type": "PROCEDURE" }, { "name": "management of therapy complications", "type": "PROCEDURE" }, { "name": "assessment of therapy complications", "type": "PROCEDURE" } ], "intervention_types": [ "OTHER", "PROCEDURE" ], "sponsor": "City of Hope Medical Center", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 280, "start_date": "2008-10", "completion_date": "2014-10", "has_results": false, "last_update_posted_date": "2015-11-06", "last_synced_at": "2026-10-23T02:01:42.752Z", "location_count": 1, "location_summary": "Duarte, California", "locations": [ { "city": "Duarte", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT00823732" } ] }